Latest Breaking News On - Michael difiore - Page 1 : vimarsana.com

Royalty Pharma : Vorasidenib Transaction Call Transcript

REFINITIV STREETEVENTS EDITED TRANSCRIPT RPRX.OQ - Royalty Pharma PLC To Host Investor Call .

United statesMichael difiore evercoreTerence flynn morgan stanleyMichael difioreTerry coynePablo legorretaGeoff meachamTerence flynnGeorge grofikMarshall uristResearch investmentsMorgan stanleyIr communicationsSusan chor bankRoyalty pharmaAgios pharmaceuticals

Fractyl Health, Inc Common Stock (NASDAQ:GUTS) Q1 2024 Earnings Call Transcript

Fractyl Health, Inc Common Stock (NASDAQ:GUTS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesElisa davidsonStephen jasperMichael difioreMike difioreAdrian kimberMorgan stanleyTimothy kiefferJason gerberryHarith rajagopalanGerman diabetes association annual meetingKaiser family foundationFractyl health incFractyl healthExchange commission

Halozyme Therapeutics, Inc (NASDAQ:HALO) Q1 2024 Earnings Call Transcript

Halozyme Therapeutics, Inc (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkRoche tecentriqVikram purohitMichael difioreNicole labrosseDemyelinating polyradiculoneuropathyHelen torleyJohnson amivantamabBristol myers squibb nivolumabJessica fyeEuropean commissionCorporate communicationsAmerican academy of neurology annual meetingMorgan stanleyHalozyme therapeutics inc

Kodiak Sciences Inc (NASDAQ:KOD) Q4 2023 Earnings Call Transcript

Kodiak Sciences Inc. misses on earnings expectations. Reported EPS is $-1.13 EPS, expectations were $-0.86. Kodiak Sciences Inc.

Pablo velasquez martinMichael yeeJohn borgesonMichael difioreVictor perlrothKodiak sciences businessKodiak sciences incExchange commissionClinical researchKodiak sciencesCall transcript marchKodiak sciences business updateChief financialIm john borgesonSenior vice presidentStarter stock portfolio

Mineralys Therapeutics, Inc (NASDAQ:MLYS) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the Mineralys Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions].

United statesKathy karidisMichael difioreMary kateJon congletonGreg harrisonGlenn sblendorioAdam levyDavid rodmanBoehringer ingelheimMineralys therapeutics incMineralys therapeuticsCall transcript novemberMineralys therapeutics third quarterDan ferryChief executive officer